Reuters logo
BRIEF-Pershing Square Capital sells investment in Valeant Pharmaceuticals
March 13, 2017 / 9:10 PM / in 9 months

BRIEF-Pershing Square Capital sells investment in Valeant Pharmaceuticals

March 13 (Reuters) - Pershing Square Capital Management Lp (IPO-PERS.L)

* Pershing Square Capital Management, L.P. announces sale of its investment in Valeant Pharmaceuticals International, Inc.

    * Pershing Square-CEO Bill Ackman, Vice Chairman Steve Fraidin to remain on Valeant board until upcoming annual meeting, will not stand for re-election

    * Pershing Square Capital Management says at its current market value, valeant position represented 1.5 percent to 3 percent of various Pershing Square funds Source text for Eikon: Further company coverage:

    0 : 0
    • narrow-browser-and-phone
    • medium-browser-and-portrait-tablet
    • landscape-tablet
    • medium-wide-browser
    • wide-browser-and-larger
    • medium-browser-and-landscape-tablet
    • medium-wide-browser-and-larger
    • above-phone
    • portrait-tablet-and-above
    • above-portrait-tablet
    • landscape-tablet-and-above
    • landscape-tablet-and-medium-wide-browser
    • portrait-tablet-and-below
    • landscape-tablet-and-below